ArticleJournal of translational internal medicine2017

The Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes.

Erin St Onge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.